{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699996042365568.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejm199709183371203"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJM199709183371203"}},{"identifier":{"@type":"NAID","@value":"30022550910"}}],"dc:title":[{"@value":"A Short-Term Trial of Tacrolimus Ointment for Atopic Dermatitis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699996042365703","@type":"Researcher","foaf:name":[{"@value":"Thomas Ruzicka"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365569","@type":"Researcher","foaf:name":[{"@value":"Thomas Bieber"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365702","@type":"Researcher","foaf:name":[{"@value":"Erwin Schöpf"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365698","@type":"Researcher","foaf:name":[{"@value":"Andris Rubins"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365570","@type":"Researcher","foaf:name":[{"@value":"Attila Dobozy"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365697","@type":"Researcher","foaf:name":[{"@value":"Jan D. Bos"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365696","@type":"Researcher","foaf:name":[{"@value":"Stefania Jablonska"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365568","@type":"Researcher","foaf:name":[{"@value":"Imitiaz Ahmed"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365701","@type":"Researcher","foaf:name":[{"@value":"Kristian Thestrup-Pedersen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365571","@type":"Researcher","foaf:name":[{"@value":"Francois Daniel"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365699","@type":"Researcher","foaf:name":[{"@value":"Aldo Finzi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996042365700","@type":"Researcher","foaf:name":[{"@value":"Sakari Reitamo"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00257850"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00284793"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"1997-09-18","prism:volume":"337","prism:number":"12","prism:startingPage":"816","prism:endingPage":"821"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJM199709183371203"}],"createdAt":"2002-07-27","modifiedAt":"2024-01-06","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285708796128640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182070314112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182070357888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204273506176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis."},{"@language":"ja","@value":"アトピー性皮膚炎治療薬タクロリムス軟膏（プロトピック軟膏）の薬理学的特性と臨床効果"},{"@value":"新薬紹介総説 アトピー性皮膚炎治療薬タクロリムス軟膏(プロトピック軟膏)の薬理学的特性と臨床効果"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ アトピーセイ ヒフエン チリョウヤク タクロリムス ナンコウ プロトピック ナンコウ ノ ヤクリガクテキ トクセイ ト リンショウ コウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204627334784","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Participation of Proteinase-Activated Receptor-2 in Passive Cutaneous Anaphylaxis-Induced Scratching Behavior and the Inhibitory Effect of Tacrolimus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204788370176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Vegetarian Diet Ameliorates Symptoms of Atopic Dermatitis through Reduction of the Number of Peripheral Eosinophils and of PGE2 Synthesis by Monocytes."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205205581568","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"0.1%タクロリムス外用療法を行った紅斑性天疱瘡の犬の1例"},{"@language":"en","@value":"Topical 0.1% Tacrolimus for Pemphigus Erythematosus in a Dog"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679609555840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Physiological Changes in the Skin on Systemic Absorption of Tacrolimus Following Topical Application in Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845712998846080","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Preclinical Study of Tacrolimus Ointment for Prevention of Its Systemic Absorption in Atopic Dermatitis Model Mice According to Their Skin Conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1520573330656694144","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of Topical Dexamethasone and Topical FK506 Treatment for the Experimental Allergic Conjunctivitis Model in Balb/c Mice"},{"@language":"ja-Kana","@value":"Comparison of Topical Dexamethasone and Topical FK506 Treatment for the Experimental Allergic Conjunctivitis Model in Balb c Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750324785920","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current and Future Concept of Atopic Eczema Treatment in Europe and USA-The Role of Tacrolimus"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700306934272","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Itch and Atopic Dermatitis : An Overview"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698599851279616","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"アトピー性皮膚炎におけるタクロリムス外用薬のEBM"},{"@language":"en","@value":"EBM of tacrolimus ointment for atopic dermatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550134684160","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Tacrolimus Ointment on Facial Eruption, Itch, and Scratching in Patients with Atopic Dermatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668925018459264","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Macrolactam Immunomodulators (Tacrolimus and Pimecrolimus) : New Horizons in the Topical Treatment of Inflammatory Skin Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950399998638336","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"IMMUNOLOGY AND THERAPY OF PSORIASIS"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231874968371584","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"アトピー性眼瞼炎の治療"},{"@language":"en","@value":"Treatment for Atopic Blepharitis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejm199709183371203"},{"@type":"CIA","@value":"30022550910"},{"@type":"CROSSREF","@value":"10.1248/bpb.b15-00727_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.1056/nejmoa1606490_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.2114/jpa.20.353_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2010.07.031_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.2736/jjvd.21.169_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.1254/fpj.117.351_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.1248/bpb.32.1173_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2009.09.043_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.43.477_references_DOI_QqLjDvziKNoGZTchPNg0E7QaHd2"}]}